Home | Login | Subscribe Today!Nov. 20, 2009

Untitled Page
Pharmacist’s Letter addresses the drug therapy issues facing pharmacists. For example:

  • How do you convert from oral estrogens to the patch, gel, or other topical forms?
  • Are topical forms safer than oral estrogens as far as lipids, clotting, CV risk?
  • What are the pros and cons of the different dosage forms?
For answers see our article: how to switch women from oral to topical estrogens

Login if you are a current subscriber to Pharmacist's Letter.
Subscribe now to get instant access and the answers you need.

Additional information is available in our Detail-Document:

Converting Between Estrogen Products

   

Up to 80% of women experience vasomotor symptoms (e.g., hot flashes, night sweats, etc) with menopause. Treatment of vasomotor symptoms is the primary indication for using estrogen therapy. Estrogen therapy is also a treatment option for preventing postmenopausal osteoporosis. There’s a wide array of products available, including oral tablets, gels, patches, and sprays. This document reviews the different routes of administration of estrogen therapy (i.e., oral, topical/transdermal, vaginal), and includes a table of approximate comparable doses.

Read more...


Click here to Subscribe Today!
Already a subscriber/Login
Home | Search or Browse | Index of Topics | Privacy Policy | Email Us
Therapeutic Research Center
3120 W. March Lane, PO Box 8190, Stockton, CA 95208, Tel:(209) 472-2240 Fax:(209) 472-2249
Copyright © 1995-2009, All rights reserved.